Content about Ofloxacin

February 9, 2012
FDA issues warning on PPI, H2 blocker antacids: May increase risk of CDAD

The Food and Drug Administration on Wednesday issued a public warning that the use of proton-pump inhibitors or H2 blockers may be associated with an increased risk of Clostridium difficile–associated diarrhea, or CDAD.

July 29, 2011
Hi-Tech Pharmacal introduces generic Levaquin

A generic version of a popular pneumonia treatment has entered the market from Hi-Tech Pharmacal.

July 25, 2011
ReportersNotebook — Chain Pharmacy, 8/1/11

The Food and Drug Administration has approved a drug made by Johnson & Johnson for treating deep vein thrombosis in patients undergoing knee or hip replacement surgery, a J&J subsidiary said.

July 20, 2011
Hi-Tech Pharmacal's generic Levaquin enters market

Hi-Tech Pharmacal has introduced levofloxacin oral solution in the 25-mg/mL strength, the drug maker said Tuesday.

June 22, 2011
Dr. Reddy's brings generic Levaquin to market

Generic drug maker Dr. Reddy’s Labs has launched its version of a popular antibiotic.

June 21, 2011
FDA approves first generic versions of Levaquin

The Food and Drug Administration Tuesday approved the first generic versions of an antibiotic designed to treat certain infections in people ages 18 years and older.

April 25, 2011
ReportersNotebook — Chain Pharmacy, 5/2/11

SUPPLIER NEWS — Hi-Tech Pharmacal announced the tentative approval by the Food and Drug Administration of levofloxacin oral solution in the 25-mg/mL strength, a generic antibiotic. Levofloxacin oral solution is a generic version of Johnson & Johnson’s Levaquin, which had sales of $6 million in 2010, according to IMS Health. Hi-Tech expected to receive final approval in June, when Johnson & Johnson’s patent expires.


April 8, 2011
Hi-Tech granted tentative approval for generic Levaquin

The Food and Drug Administration has granted tentative approval to a generic antibiotic made by Hi-Tech Pharmacal, the drug maker said Friday.

February 11, 2011
FDA approves Quixin generic

The Food and Drug Administration has approved Hi-Tech Pharmacal’s generic version of a drug for eye infections.

December 17, 2010
Don't expect 'pay-for-delay' battle to cease

Patent settlements between branded and generic drug companies, sometimes called “pay-for-delay” deals, aren’t going away any time soon.

September 9, 2010
Appeals court upholds decision to OK 'pay-for-delay' deals

The federal government got a kick in the face Thursday as an appeals court ruled...

July 13, 2010
FDA: Qualaquin has serious side effects

Unapproved use of a drug used to treat malaria can cause serious side effects, prompting...

March 10, 2010
Bayer receives orphan drug designation for CF treatment

The Food and Drug Administration has given orphan drug designation to an investigational treatment for...

January 4, 2010
FDA, health organizations to study safety of medications taken during pregnancy

A new research program called the Medication Exposure in Pregnancy Risk Evaluation will fund research...

© 2013 Drug Store News. All Rights Reserved.